AbbVieABBV

NYSE · USA · Segment 2 of 8 in the Medicine, pharma & life science value chain: Big pharma

Large biopharma with immunology (Skyrizi, Rinvoq), oncology and neuroscience.

Big pharma: Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas.

Key metrics

Market cap

$447B

Price

$248.22

Today

−0.7%

Return YTD

+9.4%

Return 1Y

+31.1%

P/E

122.8

P/S

7.1

P/B

314.5

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

Big biopharmaImmunologyOncologyNeuroscience

In the value chain

Products & services

Skyrizi & Rinvoq (immunology)
Oncology portfolio
Botox & aesthetics (Allergan)

Competitors

Johnson & Johnson
Bristol Myers Squibb
Amgen

Risks

Humira patent loss
Pipeline dependence

Same segment: Big pharma

Johnson & JohnsonJNJ Merck & Co.MRK PfizerPFE Bristol Myers SquibbBMY ZoetisZTS

See where AbbVie sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →